Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Elwing

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
The Lancet. Respiratory Medicine|December 12, 2018
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysisChristopher J Rhodes, Ken Batai, Marta Bleda, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
The Lancet. Respiratory Medicine|December 12, 2018
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysisChristopher J Rhodes, Ken Batai, Marta Bleda, et al.
Pageof 3